Legal Opinion

Heron Therapeutics, Inc. v. Azurity Pharmaceuticals, Inc.; Azurity Pharmaceuticals India LLP f/k/a Slayback Pharma India LLP; and Slayback Pharma LLC

District Court, D. Delaware

Decided October 29, 2025No. 1:24-cv-00830Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE HERON THERAPEUTICS, INC., ) ) Plaintiff, ) ) v. ) C.A. No. 24-830 (WCB) ) AZURITY PHARMACEUTICALS, INC., ) C.A. No. 24-1363 (WCB) AZURITY PHARMACEUTICALS INDIA ) LLP f/k/a SLAYBACK PHARMA INDIA ) LLP, and SLAYBACK PHARMA LLC, ) ) Defendants. ) MEMORANDUM OPNION AND ORDER The defendants in this consolidated case—Azurity Pharmaceuticals, Inc.; Azurity Pharmaceuticals India LLP f/k/a Slayback Pharma India LLP; and Slayback Pharma LLC (collectively, “Azurity”)—have lodged an objection to what they refer to as a “new theory” raised…

2Cases cited9 opinions

  1. 02 Micro International Ltd. v. Beyond Innovation Technology Co.Court of Appeals for the Federal Circuit · 2008
  2. Transmatic, Inc., Plaintiff/cross-Appellant v. Gulton Industries, Inc.Court of Appeals for the Federal Circuit · 1995
  3. Ecolab, Inc. v. Envirochem, Inc.Court of Appeals for the Federal Circuit · 2001
  4. Andersen Corp. v. Fiber Composites, LLCCourt of Appeals for the Federal Circuit · 2007
  5. Apple Inc. v. Samsung Electronics Co., Ltd.Court of Appeals for the Federal Circuit · 2016

4 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API